DOWNSTREAM PROCESS OF BIOPHARMACEUTICALS
The development of the biopharmaceuticals begins with the development of effective producers. But the more complex protein and its producer, the greater the amount of impurities is synthesized or accumulated during the upstream process. Among them are as follows: bacterial endotoxins, viruses, host...
Saved in:
| Main Author: | D. A. Gusarov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Self-Consistent, High-Fidelity Adsorption Model for Chromatographic Process Predictions: Low-to-High Load Density and Charge Variants in a Preparative Cation Exchanger
by: Gregor M. Essert, et al.
Published: (2025-06-01) -
Consecutive Affinity and Ion-Exchange Chromatography for AAV9 Vectors Purification
by: Ozgun Firat Duzenli, et al.
Published: (2025-02-01) -
On Regulating Downstream AI Developers
by: Sophie Williams, et al. -
The Paradox of Downstream Mining Industry Development in Indonesia: Analysis and Challenges
by: Atik Krustiyati, et al.
Published: (2023-07-01) -
New technological solutions in the production of high quality cyclohexanone
by: S. V. Levanova, et al.
Published: (2019-11-01)